Key result
Moroccan STEMI registry reveals prolonged management delays and ~5% in-hospital mortality.
Why the study?
As the first national Moroccan STEMI registry, the study was conducted to assess patient management modalities and highlight clinical and therapeutic characteristics across cardiology centres on a national scale.
Observational (n=809)
Yes
The first national Moroccan STEMI registry reveals significant management delays and low rates of early revascularization compared to other countries, highlighting the need for improved STEMI care networks.
Answers are grounded in this paper and cite their sources.
Substantial prehospital delays in Moroccan STEMI warrant system evaluation; leaves open whether national networks will reduce mortality.
Background MR-MI is the first national Moroccan ST-elevation myocardial infarction (STEMI) registry. Its objectives are to assess patient management modalities and highlight the clinical and therapeutic characteristics of this pathology in all cardiology centres on a national scale. Methods Adult patients presenting with STEMI within 5 days of symptoms onset were enrolled over a period of 18 weeks from April to August 2018. 57 cardiology centres distributed in 22 cities in Morocco participated in the study, including 5 university hospitals, representing 70% of Moroccan centres managing STEMI patients. A case report form was sent to the investigators in both electronic and paper forms. Sociodemographic, clinical, management, revascularization, and follow-up data were collected. Results A total of 809 patients were recruited. The population was mostly male (74.8%) with an average age of 62.6 ± 11.6 years. The most common risk factors were smoking (38.3%) arterial hypertension (30.7%), and diabetes (28%). 30% of patients were admitted within the first 6 hours of symptoms onset and 49.6% benefitted from early revascularization. Mortality rate was 5.2% in-hospital and 3.2% at the one-month follow-up. Conclusion MR-MI is the first Moroccan STEMI registry on a national scale. Relevant management delays are much longer than other countries, and less than 50% of the patients that present on time benefit from early revascularization. Efforts remain to be done on the optimal diagnosis and treatment of STEMI.
No takes yet. Share an insight, caveat, or question.
Soufiani et al. (2023) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=809). The first national Moroccan STEMI registry revealed prolonged management delays, with a median symptom-to-first medical contact of 690 minutes and an in-hospital mortality rate of 5.2%.
Synapse has enriched 10 related papers. Consider them for comparative context: